AT315820B - Verfahren zur Herstellung neuer sekundärer p-Aminophenylamidine sowie deren Säureadditionssalze - Google Patents

Verfahren zur Herstellung neuer sekundärer p-Aminophenylamidine sowie deren Säureadditionssalze

Info

Publication number
AT315820B
AT315820B AT959272A AT959272A AT315820B AT 315820 B AT315820 B AT 315820B AT 959272 A AT959272 A AT 959272A AT 959272 A AT959272 A AT 959272A AT 315820 B AT315820 B AT 315820B
Authority
AT
Austria
Prior art keywords
aminophenylamidines
preparation
acid addition
addition salts
new secondary
Prior art date
Application number
AT959272A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of AT315820B publication Critical patent/AT315820B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT959272A 1970-06-13 1971-06-11 Verfahren zur Herstellung neuer sekundärer p-Aminophenylamidine sowie deren Säureadditionssalze AT315820B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2029298A DE2029298C3 (de) 1970-06-13 1970-06-13 Aminophenylamidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
AT315820B true AT315820B (de) 1974-06-10

Family

ID=5773920

Family Applications (3)

Application Number Title Priority Date Filing Date
AT959272A AT315820B (de) 1970-06-13 1971-06-11 Verfahren zur Herstellung neuer sekundärer p-Aminophenylamidine sowie deren Säureadditionssalze
AT959172A AT313873B (de) 1970-06-13 1971-06-11 Verfahren zur Herstellung neuer sekundärer p-Aminophenylamidine sowie deren Säureadditionssalze
AT504071A AT311938B (de) 1970-06-13 1971-06-11 Verfahren zur Herstellung neuer sekundärer p-Aminophenylamidine sowie deren Säureadditionssalze

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT959172A AT313873B (de) 1970-06-13 1971-06-11 Verfahren zur Herstellung neuer sekundärer p-Aminophenylamidine sowie deren Säureadditionssalze
AT504071A AT311938B (de) 1970-06-13 1971-06-11 Verfahren zur Herstellung neuer sekundärer p-Aminophenylamidine sowie deren Säureadditionssalze

Country Status (25)

Country Link
US (1) US3818070A (de)
JP (4) JPS563341B1 (de)
AR (1) AR205686A1 (de)
AT (3) AT315820B (de)
BE (1) BE768402A (de)
CA (1) CA1000713A (de)
CH (3) CH573902A5 (de)
CS (3) CS172350B2 (de)
DE (1) DE2029298C3 (de)
DK (1) DK132075C (de)
EG (1) EG10637A (de)
ES (3) ES392166A1 (de)
FR (1) FR2100756B1 (de)
GB (1) GB1325527A (de)
HK (1) HK29976A (de)
HU (1) HU162206B (de)
IE (1) IE35362B1 (de)
IL (1) IL37023A (de)
NL (1) NL7108066A (de)
PH (1) PH10292A (de)
PL (3) PL93695B1 (de)
RO (3) RO58867A (de)
SE (1) SE366028B (de)
SU (2) SU450400A3 (de)
ZA (1) ZA713766B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013676A (en) * 1970-06-13 1977-03-22 Bayer Aktiengesellschaft Aminophenylamidines, their production and their pharmaceutical use
DE2346939A1 (de) * 1973-09-18 1975-04-03 Bayer Ag Acylamino-phenyl-acetamidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4015012A (en) * 1973-09-18 1977-03-29 Bayer Aktiengesellschaft 4-Acylaminophenylacetamidines and a method for their preparation
US4140795A (en) * 1976-12-09 1979-02-20 Ciba-Geigy Corporation Pesticidal 1,3,5-triazapenta-1,4-dienes
DE2758005A1 (de) 1977-12-24 1979-06-28 Bayer Ag Phosphonylureidobenzol-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4525663A (en) * 1982-08-03 1985-06-25 Burr-Brown Corporation Precision band-gap voltage reference circuit
JPS6118603A (ja) * 1984-07-04 1986-01-27 極東開発工業株式会社 塵芥収集車における安全装置
JPS6230943U (de) * 1985-08-09 1987-02-24
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
CN1395467A (zh) * 2000-09-07 2003-02-05 美国拜尔公司 用作孕酮受体结合剂的环和非环脒以及包含它们的药物组合物
RU2004135323A (ru) * 2002-05-03 2005-07-20 Е.И.Дюпон де Немур энд Компани (US) Соединения амидинилфенила и их применение в качестве фунгицидов
DE102007061262A1 (de) 2007-12-19 2009-06-25 Bayer Animal Health Gmbh Neue Verwendung von Tribendimidin
DE102008030764A1 (de) * 2008-06-28 2009-12-31 Bayer Animal Health Gmbh Kombination von Amidin-Derivaten mit cyclischen Depsipeptiden
CN102344391B (zh) * 2011-07-28 2013-12-25 山东新华制药股份有限公司 N-(4-乙酰氨基苯基)-n′，n′-二甲基乙脒的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182053A (en) * 1961-11-20 1965-05-04 Hoffmann La Roche Pyridine formamidines of primary amines

Also Published As

Publication number Publication date
CS172349B2 (de) 1976-12-29
AR205686A1 (es) 1976-05-31
SU469244A3 (ru) 1975-04-30
AT313873B (de) 1974-03-11
IE35362L (en) 1971-12-13
FR2100756B1 (de) 1975-01-17
DE2029298B2 (de) 1979-08-02
CA1000713A (en) 1976-11-30
HU162206B (de) 1973-01-29
RO62442A (fr) 1978-02-15
JPS55143953A (en) 1980-11-10
BE768402A (fr) 1971-12-13
JPS5634585B2 (de) 1981-08-11
CH573900A5 (de) 1976-03-31
ES395639A1 (es) 1973-11-16
EG10637A (en) 1976-04-30
PL93694B1 (de) 1977-06-30
ZA713766B (en) 1972-01-26
ES392166A1 (es) 1974-02-01
DK132075C (da) 1976-03-15
JPS5748147B2 (de) 1982-10-14
RO58867A (de) 1976-05-15
JPS5634586B2 (de) 1981-08-11
AT311938B (de) 1973-12-10
NL7108066A (de) 1971-12-15
JPS563341B1 (de) 1981-01-24
HK29976A (en) 1976-05-28
RO58997A (de) 1976-02-15
CS172348B2 (de) 1976-12-29
DE2029298C3 (de) 1980-04-17
FR2100756A1 (de) 1972-03-24
IL37023A0 (en) 1971-08-25
JPS55143954A (en) 1980-11-10
CS172350B2 (de) 1976-12-29
PL93695B1 (de) 1977-06-30
CH573902A5 (de) 1976-03-31
SE366028B (de) 1974-04-08
US3818070A (en) 1974-06-18
SU450400A3 (ru) 1974-11-15
PH10292A (en) 1976-11-08
CH573901A5 (de) 1976-03-31
ES395640A1 (es) 1973-11-16
PL89670B1 (de) 1976-12-31
JPS55143955A (en) 1980-11-10
IE35362B1 (en) 1976-01-21
IL37023A (en) 1975-08-31
DE2029298A1 (de) 1971-12-23
DK132075B (da) 1975-10-20
GB1325527A (en) 1973-08-01

Similar Documents

Publication Publication Date Title
AT277973B (de) Verfahren zur Herstellung von neuen Amino-dihalogenphenyläthylaminen sowie von deren Säureadditionssalzen
AT313873B (de) Verfahren zur Herstellung neuer sekundärer p-Aminophenylamidine sowie deren Säureadditionssalze
AT312580B (de) Verfahren zur Herstellung neuer p-Aminophenylamidine und deren Säureadditionssalze
AT315858B (de) Verfahren zur Herstellung von neuen Triazolobenzodiazepinderivaten sowie von deren Salzen
AT312575B (de) Verfahren zur Herstellung von neuen tricyclischen Iminen sowie deren Säureadditionssalzen
AT318571B (de) Verfahren zur Herstellung neuer 1-Phenoxy-2-hydroxy-3-hydroxyalkylaminopropane sowie deren Säureadditionssalze
AT313872B (de) Verfahren zur Herstellung neuer substituierter 10-Aminoalkyl-10-11-dihydro-5,10-methano-5H-dibenzo[a,d]-cycloheptene sowie deren Säureadditionssalze
AT307387B (de) Verfahren zur Herstellung neuer substituierter 2-Amino-1-phenoxyäthane sowie ihrer Säureadditionssalze
AT307428B (de) Verfahren zur Herstellung von neuen Tetrahydronaphthalinsulfonylaminopyrimidinen sowie deren Salzen
AT305986B (de) Verfahren zur Herstellung von neuen 1-Hydroxyphenyl-2-cycloalkylalkylamninoäthanal-(1)-en sowie von deren Säureadditionssalzen
AT307431B (de) Verfahren zur Herstellung neuer Sulfamoylpyrimidine sowie deren Salze
AT306705B (de) Verfahren zur Herstellung von α-substituierten 2-Aminomethyl-benzylalkoholen sowie deren Säureadditionssalzen
AT330147B (de) Verfahren zur herstellung von 2-methoxy-5-alkylsulfonylbenzamiden sowie deren saureadditionssalzen
AT321266B (de) Verfahren zur Herstellung neuer N-Aryliminoäther sowie deren Säureadditionssalze
AT323720B (de) Verfahren zur herstellung von neuen 3-(carbamoylphenoxy)-1-aminopropan-2-olen sowie deren säureadditionssalzen
AT273947B (de) Verfahren zur Herstellung von 1-Phenyl-1-aminoalkylindanen und -tetralinen sowie deren Säureadditionssalzen
AT321306B (de) Verfahren zur Herstellung von neuen 1-Vinylcarbonyl-piperazin-Derivaten sowie von deren Säureadditionssalzen
AT313902B (de) Verfahren zur Herstellung von Piperazinderivaten sowie von deren Säureadditionssalzen
AT278799B (de) Verfahren zur Herstellung von neuen Pyridyl-dihydroisochinolinen sowie von deren Säureadditionssalzen
AT286264B (de) Verfahren zur herstellung von neuen 1-phenoxy-2-aminoalkanen sowie von deren saeureadditionssalzen
AT309401B (de) Verfahren zur Herstellung von o-(2-Dialkylaminoäthoxy)-α-alkylbenzylalkoholen und deren Säureadditionssalzen
CH550201A (de) Verfahren zur herstellung von 3-azidomethyl-7-amino-3cephem-4-carbonsaeure sowie deren salze.
AT294831B (de) Verfahren zur Herstellung neuer substituierter 3-Amino-4-halogen-sydnonimine und deren Säureadditionssalze
AT302315B (de) Verfahren zur Herstellung neuer Benzodiazepin-Verbindungen und deren Säureadditionssalzen
AT286268B (de) Verfahren zur Herstellung von neuen Amino-dihalogenphenyläthanolaminen sowie von deren Säureadditionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee